Medicare Enrolled
Dr. Dahlia Carr, MD
Rheumatology · Beverly Hills, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Carr from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Carr?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Carr
Dr. Dahlia Carr is a rheumatology specialist in Beverly Hills, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Carr performed 43,580 Medicare services across 3,072 unique beneficiaries.
Between the years covered by Open Payments, Dr. Carr received a total of $14,042 from 40 pharmaceutical and/or device companies across 625 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Carr is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 11% volume in CA
$14,042 industry payments
Medicare Practice Summary
Medicare Utilization ↗43,580
Medicare services
Top 11% in CA for rheumatology
3,072
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,294 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Romosozumab injection (Evenity) for osteoporosis | 20,122 | $8 | $21 |
| Denosumab injection (Prolia/Xgeva) | 19,140 | $18 | $40 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
749 | $105 | $200 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
308 | $68 | $162 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
242 | $12 | $40 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
228 | $8 | $10 |
| Erythrocyte sedimentation rate (ESR) test A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine. |
215 | $4 | $15 |
| Direct bilirubin level test A blood test that measures the amount of direct bilirubin in your body. Direct bilirubin is the form of the waste product processed by the liver. |
214 | $5 | $15 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
214 | $5 | $15 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
214 | $4 | $17 |
| Cardiac enzyme level (CK-MB) test A blood test that measures the total level of creatine kinase, specifically the cardiac enzyme fraction, to help evaluate heart muscle damage. |
212 | $6 | $23 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
211 | $10 | $32 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
208 | $8 | $27 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
205 | $5 | $18 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
122 | $29 | $85 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
107 | $44 | $239 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
104 | $14 | $61 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
103 | $15 | $35 |
| Methylprednisolone acetate injection, 20 mg A 20 mg injection of methylprednisolone acetate, a corticosteroid medication. This code specifies the drug and dosage administered. |
61 | $5 | $10 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
60 | $49 | $100 |
| New patient office visit, complex (60-74 min) | 59 | $175 | $475 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
54 | $7 | $18 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
49 | $9 | $32 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
49 | $16 | $59 |
| Lidocaine HCl injection for IV infusion, 10 mg Administration of a 10 mg dose of lidocaine hydrochloride via intravenous infusion. |
47 | $0 | $10 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
45 | $1 | $20 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
40 | $10 | $30 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
37 | $55 | $170 |
| Parathyroid hormone level test A blood test that measures the amount of parathyroid hormone in your body. This hormone helps regulate calcium levels in the blood and bones. |
27 | $40 | $85 |
| Injection, methylprednisolone acetate, 40 mg | 27 | $6 | $20 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
22 | $13 | $48 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
21 | $4 | $11 |
| Iron level test | 20 | $6 | $23 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
20 | $9 | $26 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
12 | $76 | $140 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
12 | $34 | $45 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
91.7% medium
8.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,042
Total received (2018-2024)
Avg $2,006/year across 7 years
Top 23% in CA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
625
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,042 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,249
2023
$1,924
2022
$2,063
2021
$1,859
2020
$1,044
2019
$2,420
2018
$2,483
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$612
ABBVIE INC.
$460
GlaxoSmithKline, LLC.
$286
Mallinckrodt Hospital Products Inc.
$221
Janssen Biotech, Inc.
$213
Radius Health, Inc.
$162
Boehringer Ingelheim Pharmaceuticals, Inc.
$51
AstraZeneca Pharmaceuticals LP
$39
UCB, Inc.
$37
Kiniksa Pharmaceuticals International, plc
$32
Organon Llc
$28
PFIZER INC.
$27
Genentech USA, Inc.
$21
DePuy Synthes Sales Inc.
$21
Novartis Pharmaceuticals Corporation
$20
Lilly USA, LLC
$20
Top 3 companies account for 60.4% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$3,557
Janssen Biotech, Inc.
$1,583
GlaxoSmithKline, LLC.
$1,552
Radius Health, Inc.
$879
Novartis Pharmaceuticals Corporation
$626
ABBVIE INC.
$619
PFIZER INC.
$526
Lilly USA, LLC
$508
AbbVie Inc.
$488
AbbVie, Inc.
$462
Mallinckrodt Hospital Products Inc.
$405
UCB, Inc.
$352
Celgene Corporation
$298
Boehringer Ingelheim Pharmaceuticals, Inc.
$196
DePuy Synthes Sales Inc.
$187
AstraZeneca Pharmaceuticals LP
$172
Horizon Therapeutics plc
$165
Mallinckrodt Enterprises LLC
$164
GENZYME CORPORATION
$152
Mallinckrodt LLC
$133
Sobi, Inc
$128
Janssen Scientific Affairs, LLC
$111
Cumberland Pharmaceuticals, Inc.
$68
MEDAC PHARMA, INC.
$64
Flexion Therapeutics, Inc.
$64
Bioventus LLC
$64
Horizon Pharma plc
$63
Genentech USA, Inc.
$62
Kiniksa Pharmaceuticals, Ltd.
$61
SOBI, INC
$53
Fresenius Kabi USA, LLC
$53
E.R. Squibb & Sons, L.L.C.
$48
Kiniksa Pharmaceuticals International, plc
$32
Organon Llc
$28
SANOFI-AVENTIS U.S. LLC
$23
MEDEXUS PHARMA, INC.
$23
Zimmer Biomet Holdings, Inc.
$22
Ultragenyx Pharmaceutical Inc.
$21
Antares Pharma, Inc.
$18
Aurinia Pharma U.S., Inc.
$13
Top 3 companies account for 47.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · Arcalyst · BENLYSTA · COSENTYX · CYLTEZO · Cimzia · Durolane · EVENITY · Enbrel · FORTEO · HADLIMA · HUMIRA · Humira · IDACIO · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · MONOVISC · OFEV · ORENCIA · ORTHOVISC · Otezla · Prolia · RAYOS · REDITREX · REMICADE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · Sports Medicine Product Portfolio · TALTZ · TAVNEOS · TREMFYA · Tymlos · XELJANZ · XYOSTED · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Rheumatologists within 10 mi
203
Per 100K population
2.1
County median income
$87,760
Nearest hospital
CEDARS-SINAI MEDICAL CENTER
0.8 mi
0.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Carr is a mixed practice specialist, with above-average Medicare volume (top 11% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Carr experienced with romosozumab injection (evenity) for osteoporosis?
Based on Medicare claims data, Dr. Carr performed 20,122 romosozumab injection (evenity) for osteoporosis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Carr receive payments from pharmaceutical companies?
Yes. Dr. Carr received a total of $14,042 from 40 companies across 625 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Carr's costs compare to other rheumatologists in Beverly Hills?
Dr. Carr's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Carr) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Beverly Hills
Browse rheumatologists in Beverly Hills ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in CA
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in CA
Which CA rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology